Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-25

FDA Approved: ATOVAQUONE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved the original application for atovaquone, including the oral suspension, from PAI Holdings, LLC dba PAI Pharma, marking approval of a generic produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATOVAQUONE ORAL SUSPENSION (Atovaquone oral suspension)
  • Atovaquone (Atovaquone)

Snippet

ORIG AP for ATOVAQUONE (ATOVAQUONE)